CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib
Journal of Cancer Research and Therapeutics, 07/27/2012
Clinical Article
Na II et al. – The data suggest that, in addition to epidermal growth factor receptor (EGFR) mutational status, T–stage based on computed tomography (CT) is predictive of outcomes of tyrosin kinase inhibitor (TKI)–treated non–small–cell lung cancer (NSCLC) patients.



